Stocks Consumer staples GRDN
NYSE · Consumer staplesGuardian Pharmacy Services, Inc. (GRDN)
Guardian Pharmacy Services, Inc. brought in $1.5B of revenue over the twelve months to September 30, 2026, up 4.9% from a year earlier. Net income was $74.8M, a net margin of 5.1%. Operating cash flow minus capital spending left $86.8M of free cash flow in fiscal 2025. At September 30, 2026 it held $119.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about Guardian Pharmacy Services, Inc.
- Net worth
- Guardian Pharmacy Services, Inc. has a market value (market cap) of $3.2B at the latest share price, and shareholders' equity of $279.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $1.4B (+17.9% year on year), with net income of $49.2M. Over the 12 months to September 30, 2026: revenue $1.5B, net income $74.8M.
- Cash flow
- In fiscal 2025 operations brought in $100.3M of cash; after $13.4M of capital spending, free cash flow was $86.8M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Guardian Pharmacy Services, Inc.'s next report is expected around January 12, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Guardian Pharmacy Services, Inc. does
Guardian Pharmacy Services, Inc. is registered with the SEC under industry code SIC 5912 (Retail-Drug Stores and Proprietary Stores). Its shares trade on NYSE under the ticker GRDN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.4B | $49.2M | n/a | $86.8M |
| 2025 | $1.2B | -$110M | n/a | $43.3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where GRDN ranks in Consumer staples
Latest SEC filings
What Guardian Pharmacy Services, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 1.7% to $371.1M versus the same quarter last year; diluted EPS $0.29 versus $0.15.
- November 5, 2026
- November 5, 2026Passive stake changed SCHEDULE 13G/A
- September 28, 2026Activist stake changed SCHEDULE 13D/A
- September 10, 2026Other event 8-K
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 2.2% to $351.8M versus the same quarter last year; net income rose 142% to $21.9M.
- August 6, 2026
- June 22, 2026
- May 28, 2026
- May 7, 2026
Insider trades
What the people running Guardian Pharmacy Services, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 11 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 27, 2026 | Bindley William EDirector, 10% owner | Exercised optionsindirect | 6,100,175 | - |
| September 27, 2026 | Forbes KendallMember of 10% Owner Group | Exercised options | 608,570 | - |
| September 27, 2026 | Tuch JeffreySee Remarks | Exercised options | 55,578 | - |
| September 27, 2026 | Burke FredSee Remarks, Director | Exercised options | 1,298,825 | - |
| September 27, 2026 | Pharmacy Investors, LLCMember of 10% Owner Group | Exercised options | 1,413,939 | - |
| September 27, 2026 | Martin David NormanSee Remarks | Exercised options | 39,865 | - |
| September 27, 2026 | Salentine Thomas J JrDirector, 10% owner | Exercised optionsindirect | 6,100,175 | - |
| September 27, 2026 | Ackerman JohnDirector | Exercised optionsindirect | 1,413,939 | - |
Who owns GRDN
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Thomas J. Salentine, Jr.13D, may seek influence with 8 related filers | 26.4% | September 28, 2026 |
| Fmr LLC13G, passive with 1 related filers | 6.5% | May 6, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 189 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Fmr LLC | 3,241,612 | +882,255 |
| Wellington Management Group Llp | 1,729,032 | -36,087 |
| BlackRock, Inc. | 1,575,989 | -180,385 |
| Vanguard Capital Management LLC | 1,379,750 | +154,207 |
| Woodline Partners LP | 1,306,340 | +22 |
| Valiant Capital Management, L.P. | 1,186,658 | 0 |
| Boston Partners | 983,868 | -33,815 |
| Franklin Resources Inc | 966,206 | +13,254 |
| TimesSquare Capital Management, LLC | 951,637 | -125,837 |
| Loomis Sayles & Co L P | 869,836 | -61,853 |
| Boone Capital Management LLC | 711,939 | +80,746 |
| Geode Capital Management, LLC | 646,695 | +87,660 |
| Jennison Associates LLC | 626,664 | -196,120 |
| State Street Corp | 590,114 | +81,096 |
| Brown Advisory Inc | 524,013 | -735,161 |
| Dimensional Fund Advisors LP | 516,094 | +307,500 |
| Driehaus Capital Management LLC | 510,161 | -78,960 |
| First Trust Advisors LP | 461,307 | +367,630 |
| Aristotle Capital Boston, LLC | 422,427 | -73,429 |
| Silvercrest Asset Management Group LLC | 345,229 | -29,717 |
Insiders
16 insiders reported holding 56,533,496 shares in total, about $2.83B at the last price.
| Holder | Shares |
|---|---|
| Salentine Thomas J JrDirector, 10% owner | 16,669,66616,669,666 held indirectly |
| Bindley William EDirector, 10% owner | 16,669,66616,669,666 held indirectly |
| Bindley Capital Partners I, LLC10% owner | 10,569,491 |
| Pharmacy Investors, LLCMember of 10% Owner Group | 3,863,806 |
| Burke FredSee Remarks, Director | 3,438,064 |
| Forbes KendallMember of 10% Owner Group | 1,651,059 |
| Ackerman JohnDirector | 1,287,2371,287,237 held indirectly |
| Morris David KSee Remarks, Director | 896,341 |
| Cardinal Equity Fund, L.P.Member of 10% owner group | 816,180 |
| Tuch JeffreySee Remarks | 231,847 |
Questions about GRDN
What does Guardian Pharmacy Services, Inc. do?
Guardian Pharmacy Services, Inc. is a company in the Consumer staples sector, listed on NYSE as GRDN. Its shares trade on NYSE under the ticker GRDN.
What is Guardian Pharmacy Services, Inc.'s net worth?
Guardian Pharmacy Services, Inc. has a market value (market cap) of $3.2B at the latest share price, and shareholders' equity of $279.7M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Guardian Pharmacy Services, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $74.8M on revenue of $1.5B, a net margin of 5.1%.
How much revenue does Guardian Pharmacy Services, Inc. make?
Over the twelve months to September 30, 2026 Guardian Pharmacy Services, Inc. reported revenue of $1.5B. That is 4.9% more than a year earlier.
When did Guardian Pharmacy Services, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is Guardian Pharmacy Services, Inc.'s next earnings report?
Guardian Pharmacy Services, Inc.'s next report is expected around January 12, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare GRDN with
Follow GRDN
Get an email when Guardian Pharmacy Services, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Guardian Pharmacy Services, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.